Examination of the Pancreas in New-onset Diabetes (EXPAND)
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
Full description
Compared to the general population, subjects >50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patient Characteristics:
--Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values
- No acute illness or steroid therapy
- No prior pancreas surgery
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal